Release Date: 05/12/14 12:11 Summary: Appendix 3B Price Sensitive: No Download Document 790.6KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans